BCBP
BCB Bancorp, Inc.
There isn't enough reported data to score BCBP yet.
MS
Morgan Stanley
MS's fundamentals are strong: revenue grew 16% and earnings per share grew 29%. At 15x earnings, it's trading in line with its usual 14x. Analysts expect earnings growth.
BCBP Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| N/A | |
| N/A |
BCBP's revenue is currently stable, but its profitability is weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like BCBP.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
BCBP PE Valuation
BCBP has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 19x next year's earnings.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
BCBP Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect BCBP to return to profit, with revenue growing. However, they disagree widely on these estimates.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
BCBP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.47 | — |
| Q3 2026 | -$8.24 | -13833% |
| Q2 2026 | -$1.10 | -650% |
| Q1 2026 | -$0.07 | -144% |
| Q4 2025 | -$0.84 | -185% |
| Q3 2025 | $0.06 | -95% |
| Q2 2025 | $0.20 | -83% |
| Q1 2025 | $0.16 | -90% |
| Q4 2024 | $0.99 | -42% |
BCBP has swung to a loss: it lost $8.24 per share over the past year, after a profit the year before.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over BCBP on earnings quality, reporting a profit while its opponent remains loss making.
BCBP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $27.8M | +5% |
| Q2 2026 | $22.9M | -9.1% |
| Q1 2026 | $24.9M | +4.8% |
| Q4 2025 | $26.2M | +13% |
| Q3 2025 | $26.5M | +1.1% |
| Q2 2025 | $25.2M | +23% |
| Q1 2025 | $23.8M | -5.8% |
| Q4 2024 | $23.1M | -15% |
BCBP's revenue has held roughly level: $28M last quarter, up 5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -392% | -414 points |
| Q2 2026 | -80% | -100 points |
| Q1 2026 | 26% | +76 points |
| Q4 2025 | -67% | -87 points |
| Q3 2025 | 22% | -14 points |
| Q2 2025 | 20% | +0.4 points |
| Q1 2025 | -49% | -82 points |
| Q4 2024 | 20% | -12 points |
BCBP's operating margin was −392% last quarter, down 414 points from the same quarter a year ago, near the bottom of its range since 2019.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over BCBP on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS has the edge over BCBP on profitability, with a higher operating margin.
BCBP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.7M | -44% |
| Q2 2026 | $9.3M | -8.2% |
| Q1 2026 | $4.9M | +4% |
| Q4 2025 | $11.5M | +69% |
| Q3 2025 | $8.5M | -81% |
| Q2 2025 | $10.2M | +26% |
| Q1 2025 | $4.7M | -42% |
| Q4 2024 | $6.8M | +1339% |
BCBP has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
BCBP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +11% | +1.8M shares |
| 1 year | +11% | +1.9M shares |
| 3 years | +14% | +2.3M shares |
| 5 years | +11% | +1.9M shares |
| Available history | +17% | +2.7M shares |
BCBP has 19M diluted shares, up 11% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | $1.3M |
| Q1 2023 | $2.6M |
| Q4 2022 | $1.4M |
| Q3 2022 | $1.2M |
| Q2 2022 | $756,000 |
| Q1 2022 | $8,000 |
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over BCBP on shareholder dilution, with a more favorable share count trend.
BCBP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 19.3x | High |
| Q3 2025 | 5.7x | High |
| Q2 2025 | 3.5x | Elevated |
| Q1 2025 | 3.9x | Elevated |
| Q4 2024 | 17.3x | High |
| Q3 2024 | 1.7x | Healthy |
| Q2 2024 | 0.8x | Very low |
| Q1 2024 | 0.6x | Very low |
BCBP's net debt is about 19 years of its operating earnings (EBITDA), up from 17 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BCBP.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
BCBP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.8 | Neutral |
| Stochastic | 60.5 | Neutral |
BCBP's weekly RSI is 52 (neutral) and its Stochastic is 60 (neutral).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
BCBP PE vs Financial Services Sector
| Metric | BCBP | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
BCBP has no meaningful PE right now: it lost money over the past year.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
BCBP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.68 | 5.6% above |
| 20 week MA | $9.09 | 0.9% above |
| 50 week MA | $9.06 | 1.2% above |
| 100 week MA | $9.09 | 0.9% above |
| 200 week MA | $10.6 | 13% below |
BCBP has the edge over MS on trend strength, trading above more of its moving averages.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
BCBP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $13.9 | $10.8 | -22% |
| 2021 | $10.8 | $15.6 | +45% |
| 2022 | $15.6 | $18.0 | +16% |
| 2023 | $18.0 | $12.9 | -29% |
| 2024 | $12.9 | $11.7 | -9.3% |
| 2025 | $11.7 | $8.27 | -29% |
| 2026 YTD | $8.27 | $9.17 | +11% |
BCBP has the edge over MS on returns for 2026, with the stronger performance.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has finished higher in five of the last six years. It's up 4% so far in 2026.